Interaction of G-rich GT oligonucleotides with nuclear-associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell lines

FEBS J. 2006 Apr;273(7):1350-61. doi: 10.1111/j.1742-4658.2006.05143.x.

Abstract

G-rich GT oligonucleotides with a different content of G clusters have been evaluated for their ability to exert cytotoxicity and to bind to nuclear-associated proteins in T-lymphoblast CCRF-CEM cells. Only the oligomers that did not form G-based structures or had a poor structure, under physiological conditions, were able to exert significant cellular growth inhibition effect. The cytotoxicity of these oligomers was related to their binding to the nuclear-associated eEF1A protein, but not to the recognition of nucleolin or other proteins. In particular, GT oligomers adopting a conformation compatible with G-quadruplex, did not exert cytotoxicity and did not bind to eEF1A. The overall results suggest that the ability of oligomers to adopt a G-quadruplex-type secondary structure in a physiological buffer containing 150 mM NaCl is not a prerequisite for antiproliferative effect in haematopoietic cancer cells. The cytotoxicity of G-rich GT oligomers was shown to be tightly related to their binding affinity for eEF1A protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / metabolism
  • Antineoplastic Agents* / toxicity
  • Base Sequence
  • Biomarkers, Tumor / metabolism
  • Cell Line, Tumor
  • Cell Proliferation*
  • Humans
  • Nucleic Acid Conformation
  • Nucleic Acid Denaturation
  • Oligonucleotides* / chemistry
  • Oligonucleotides* / genetics
  • Oligonucleotides* / metabolism
  • Oligonucleotides* / toxicity
  • Oncogene Proteins / genetics
  • Oncogene Proteins / metabolism*
  • Peptide Elongation Factor 1 / genetics
  • Peptide Elongation Factor 1 / metabolism*
  • Protein Binding
  • T-Lymphocytes / cytology
  • T-Lymphocytes / physiology*

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • EEF1A1 protein, human
  • Oligonucleotides
  • Oncogene Proteins
  • Peptide Elongation Factor 1